Loading...
Practice changing mature results of RTOG study 9802: another positive PCV trial makes adjuvant chemotherapy part of standard of care in low-grade glioma
The long-term follow-up of the RTOG 9802 trial that compared 54 Gy of radiotherapy (RT) with the same RT followed by adjuvant procarbazine, CCNU, and vincristine (PCV) chemotherapy in high-risk low-grade glioma shows a major increase in survival after adjuvant PCV chemotherapy. Median overall surviv...
Na minha lista:
| Udgivet i: | Neuro Oncol |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4232091/ https://ncbi.nlm.nih.gov/pubmed/25355680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou297 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|